Literature DB >> 10395215

hKCa3/KCNN3 potassium channel gene: association of longer CAG repeats with schizophrenia in Israeli Ashkenazi Jews, expression in human tissues and localization to chromosome 1q21.

V Dror1, E Shamir, S Ghanshani, R Kimhi, M Swartz, Y Barak, R Weizman, L Avivi, T Litmanovitch, E Fantino, K Kalman, E G Jones, K G Chandy, J J Gargus, G A Gutman, R Navon.   

Abstract

We demonstrate a significant association between longer CAG repeats in the hKCa3/KCNN3 calcium-activated potassium channel gene and schizophrenia in Israeli Ashkenazi Jews. We genotyped alleles from 84 Israeli Jewish patients with schizophrenia and from 102 matched controls. The overall allele frequency distribution is significantly different in patients vs controls (P = 0.00017, Wilcoxon Rank Sum test), with patients showing greater lengths of the CAG repeat. Northern blots reveal substantial levels of approximately 9 kb and approximately 13 kb hKCa3/KCNN3transcripts in brain, striated muscle, spleen and lymph nodes. Within the brain, hKCa3/KCNN3transcripts are most abundantly expressed in the substantia nigra, lesser amounts are detected in the basal ganglia, amygdala, hippocampus and subthalamic nuclei, while little is seen in the cerebral cortex, cerebellum and thalamus. In situ hybridization reveals abundant hKCa3/KCNN3 message localized within the substantia nigra and ventral tegmental area, and along the distributions of dopaminergic neurons from these regions into the nigrostriatal and mesolimbic pathways. FISH analysis shows that hKCa3/KCNN3 is located on chromosome 1q21.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10395215     DOI: 10.1038/sj.mp.4000508

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  18 in total

Review 1.  Candidate-gene association studies of schizophrenia.

Authors:  M C O'Donovan; M J Owen
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

Review 2.  Genetic analyses of schizophrenia.

Authors:  C N Pato; K M Schindler; M T Pato
Journal:  Curr Psychiatry Rep       Date:  2000-04       Impact factor: 5.285

Review 3.  Genetics of schizophrenia and the new millennium: progress and pitfalls.

Authors:  M Baron
Journal:  Am J Hum Genet       Date:  2001-01-17       Impact factor: 11.025

Review 4.  Recent advances in the genetics of schizophrenia.

Authors:  D M Waterwort; A S Bassett; L M Brzustowicz
Journal:  Cell Mol Life Sci       Date:  2002-02       Impact factor: 9.261

Review 5.  Unraveling monogenic channelopathies and their implications for complex polygenic disease.

Authors:  J Jay Gargus
Journal:  Am J Hum Genet       Date:  2003-03-07       Impact factor: 11.025

6.  Genomewide linkage scan for schizophrenia susceptibility loci among Ashkenazi Jewish families shows evidence of linkage on chromosome 10q22.

Authors:  M Daniele Fallin; Virginia K Lasseter; Paula S Wolyniec; John A McGrath; Gerald Nestadt; David Valle; Kung-Yee Liang; Ann E Pulver
Journal:  Am J Hum Genet       Date:  2003-08-15       Impact factor: 11.025

7.  Ion channels and schizophrenia: a gene set-based analytic approach to GWAS data for biological hypothesis testing.

Authors:  Kathleen Askland; Cynthia Read; Chloe O'Connell; Jason H Moore
Journal:  Hum Genet       Date:  2011-08-25       Impact factor: 4.132

8.  Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22.

Authors:  L M Brzustowicz; K A Hodgkinson; E W Chow; W G Honer; A S Bassett
Journal:  Science       Date:  2000-04-28       Impact factor: 47.728

9.  Electrophysiological characterization of the SK channel blockers methyl-laudanosine and methyl-noscapine in cell lines and rat brain slices.

Authors:  Jacqueline Scuvée-Moreau; Andre Boland; Amaury Graulich; Lionel Van Overmeire; Dieter D'hoedt; Fabienne Graulich-Lorge; Elizabeth Thomas; Aude Abras; Martin Stocker; Jean-Francois Liégeois; Vincent Seutin
Journal:  Br J Pharmacol       Date:  2004-10-25       Impact factor: 8.739

Review 10.  Molecular and cellular basis of small--and intermediate-conductance, calcium-activated potassium channel function in the brain.

Authors:  P Pedarzani; M Stocker
Journal:  Cell Mol Life Sci       Date:  2008-10       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.